These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1111 related items for PubMed ID: 33179247

  • 21. Brivaracetam add-on therapy for drug-resistant epilepsy.
    Bresnahan R, Panebianco M, Marson AG.
    Cochrane Database Syst Rev; 2019 Mar 28; 3(3):CD011501. PubMed ID: 30920649
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Stiripentol add-on therapy for drug-resistant focal epilepsy.
    Brigo F, Igwe SC, Bragazzi NL.
    Cochrane Database Syst Rev; 2020 May 26; 5(5):CD009887. PubMed ID: 32468572
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.
    Mbizvo GK, Dixon P, Hutton JL, Marson AG.
    Cochrane Database Syst Rev; 2012 Sep 12; 2012(9):CD001901. PubMed ID: 22972056
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Felbamate add-on therapy for drug-resistant focal epilepsy.
    Shi LL, Bresnahan R, Martin-McGill KJ, Dong J, Ni H, Geng J.
    Cochrane Database Syst Rev; 2022 Aug 01; 8(8):CD008295. PubMed ID: 35914010
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Tiagabine add-on therapy for drug-resistant focal epilepsy.
    Bresnahan R, Martin-McGill KJ, Hutton JL, Marson AG.
    Cochrane Database Syst Rev; 2019 Oct 14; 10(10):CD001908. PubMed ID: 31608990
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Lacosamide add-on therapy for partial epilepsy.
    Weston J, Shukralla A, McKay AJ, Marson AG.
    Cochrane Database Syst Rev; 2015 Jun 16; (6):CD008841. PubMed ID: 26077821
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ, Marson AG, Tudur Smith C.
    Cochrane Database Syst Rev; 2019 Jul 18; 7(7):CD001911. PubMed ID: 31318037
    [Abstract] [Full Text] [Related]

  • 35. Stiripentol add-on therapy for drug-resistant focal epilepsy.
    Brigo F, Igwe SC, Bragazzi NL.
    Cochrane Database Syst Rev; 2022 Sep 06; 9(9):CD009887. PubMed ID: 36066395
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.
    Eaton C, Yong K, Walter V, Mbizvo GK, Rhodes S, Chin RF.
    Cochrane Database Syst Rev; 2022 Jul 13; 7(7):CD013136. PubMed ID: 35844168
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.